Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
Amy E. DeZern(Johns Hopkins University), Robert A. Brodsky(Johns Hopkins University), Gary L. Rosner(Johns Hopkins University), Heather J. Symons(Johns Hopkins University), Philip Imus(Sidney Kimmel Cancer Center), Nina D. Wagner‐Johnston(Sidney Kimmel Comprehensive Cancer Center), Ivan Borrello(Tampa General Hospital), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Kenneth R. Cooke(Johns Hopkins University), Leo Luznik(Johns Hopkins University), Marianna Zahurak(Bloomberg (United States)), Ephraim J. Fuchs(Johns Hopkins University), Richard F. Ambinder(Johns Hopkins University), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Douglas E. Gladstone(Northwell Health), Lode J. Swinnen(Johns Hopkins University), Javier Bolaños‐Meade(Johns Hopkins University)
Cited by 149
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k